Introduction to Clinical Oncology Cancer Grading | |
Portfolio
Did You Know... |
Cancer Grading
Grading is based on the review of tissue by a pathologist and has to do with how the cancer cells look and thus about how they are expected to grow and spread. Like staging, tumour grade is important when making decisions about treatment and when talking with patients about prognosis and the expected course of disease.
Grading considers:
Histological grade or differentiation is about how closely the tumour cells resemble the cells from which they originated. Well-differentiated tumours are considered to be prognostically more favourable than undifferentiated.
Nuclear grade refers to the size and shape of the nucleus in tumour cells and the percentage of tumour cells dividing - those with a low nuclear grade grow and spread less quickly than cancers with high nuclear grade.
There are different grading systems for each type of cancer. For example, pathologists use the Gleason system to describe the degree of differentiation of prostate cancer cells. The Gleason system uses scores ranging from Grade 2 to Grade 10. Lower Gleason scores describe well-differentiated, less aggressive tumors. Higher scores describe poorly differentiated, more aggressive tumors.
Bowel cancer scenario
|